Immix Biopharma, Inc. (IMMX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-20 | 8-K | Other Events | SEC |
| 2026-05-29 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-21 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-21 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-30 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-25 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-12-08 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-08 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-11-26 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-08 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-06-23 | 8-K | Shareholder Vote Results | SEC |
| 2025-06-03 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-07-26 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-22 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-20 | 8-K | Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-06 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-05 | 8-K | Other Events | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.